Home > Insider Trading > Filing (0001209191-22-035994)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1632384	C Joseph Galante	2525 West End Avenue Suite 950 Nashville TN 37203		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-05-02	61	$2.45	45,763	No	4	P	Direct
Common Stock	Acquisiton	2022-05-03	61	$2.42	45,824	No	4	P	Direct
Common Stock	Acquisiton	2022-05-04	61	$2.37	45,885	No	4	P	Direct
Common Stock	Acquisiton	2022-05-05	61	$2.35	45,946	No	4	P	Direct
Common Stock	Acquisiton	2022-05-06	61	$2.36	46,007	No	4	P	Direct
Common Stock	Acquisiton	2022-05-09	68	$2.63	46,075	No	4	P	Direct
Common Stock	Acquisiton	2022-05-10	68	$2.55	46,143	No	4	P	Direct
Common Stock	Acquisiton	2022-05-11	68	$2.37	46,211	No	4	P	Direct
Common Stock	Acquisiton	2022-05-12	68	$2.23	46,279	No	4	P	Direct
Common Stock	Acquisiton	2022-05-13	68	$2.32	46,347	No	4	P	Direct
Common Stock	Acquisiton	2022-05-16	68	$2.31	46,415	No	4	P	Direct
Common Stock	Acquisiton	2022-05-17	68	$2.35	46,483	No	4	P	Direct
Common Stock	Acquisiton	2022-05-18	68	$2.31	46,551	No	4	P	Direct
Common Stock	Acquisiton	2022-05-19	68	$2.29	46,619	No	4	P	Direct
Common Stock	Acquisiton	2022-05-20	68	$2.23	46,687	No	4	P	Direct
Common Stock	Acquisiton	2022-05-23	76	$2.17	46,763	No	4	P	Direct
Common Stock	Acquisiton	2022-05-24	76	$2.17	46,839	No	4	P	Direct
Common Stock	Acquisiton	2022-05-25	76	$2.15	46,915	No	4	P	Direct
Common Stock	Acquisiton	2022-05-26	76	$2.12	46,991	No	4	P	Direct
Common Stock	Acquisiton	2022-05-27	76	$2.13	47,067	No	4	P	Direct
Common Stock	Acquisiton	2022-05-31	76	$2.13	47,143	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.